Terms: = Prostate cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
341 results:
1. Prognostic Values of Gene Copy Number Alterations in prostate cancer.
Alfahed A; Ebili HO; Almoammar NE; Alasiri G; AlKhamees OA; Aldali JA; Al Othaim A; Hakami ZH; Abdulwahed AM; Waggiallah HA
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239316
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
Natani S; Ramakrishna M; Nallavolu T; Ummanni R
Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
[TBL] [Abstract] [Full Text] [Related]
3. Opportunities for Achieving the cancer Moonshot Goal of a 50% Reduction in cancer Mortality by 2047.
Shiels MS; Lipkowitz S; Campos NG; Schiffman M; Schiller JT; Freedman ND; Berrington de González A
Cancer Discov; 2023 May; 13(5):1084-1099. PubMed ID: 37067240
[TBL] [Abstract] [Full Text] [Related]
4. Integrative Pan-cancer Genomic and Transcriptomic Analyses of Refractory Metastatic cancer.
Pradat Y; Viot J; Yurchenko AA; Gunbin K; Cerbone L; Deloger M; Grisay G; Verlingue L; Scott V; Padioleau I; Panunzi L; Michiels S; Hollebecque A; Jules-Clément G; Mezquita L; Lainé A; Loriot Y; Besse B; Friboulet L; André F; Cournède PH; Gautheret D; Nikolaev SI
Cancer Discov; 2023 May; 13(5):1116-1143. PubMed ID: 36862804
[TBL] [Abstract] [Full Text] [Related]
5. Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells.
Bhat TA; Dheeraj A; Nambiar DK; Singh SP; Yim DS; Singh RP
Prostate; 2023 May; 83(6):534-546. PubMed ID: 36597263
[TBL] [Abstract] [Full Text] [Related]
6. Risk Allele Frequency Analysis and Risk Prediction of Single-Nucleotide Polymorphisms for prostate cancer.
Yoon BW; Shin HT; Seo JH
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360276
[TBL] [Abstract] [Full Text] [Related]
7. Role of Genetic Variations in
Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
[TBL] [Abstract] [Full Text] [Related]
8. Genetic and epigenetic bases of prostate tumor cell radioresistance.
Kutilin D
Klin Onkol; 2021; 34(3):220-234. PubMed ID: 34362257
[TBL] [Abstract] [Full Text] [Related]
9. Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience.
Hopland OA; Fosså SD; Ottosson F; Brennhovd B; Svindland A; Hole KH; Hernes E; Eri LM; Diep LM; Berge V
Scand J Urol; 2021 Aug; 55(4):287-292. PubMed ID: 34196594
[TBL] [Abstract] [Full Text] [Related]
10. Genetic and epigenetic bases of prostate tumor cell radioresistance.
Kutilin Denis
Ceska Gynekol; 2021; 86(3):220-234. PubMed ID: 34192880
[TBL] [Abstract] [Full Text] [Related]
11. The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Maimaiti M; Sakamoto S; Sugiura M; Kanesaka M; Fujimoto A; Matsusaka K; Xu M; Ando K; Saito S; Wakai K; Imamura Y; Nakayama K; Kanai Y; Kaneda A; Ikehara Y; Ikeda JI; Anzai N; Ichikawa T
Sci Rep; 2021 Jun; 11(1):11478. PubMed ID: 34075107
[TBL] [Abstract] [Full Text] [Related]
12. The inhibitory effect of melatonin on human prostate cancer.
Shen D; Ju L; Zhou F; Yu M; Ma H; Zhang Y; Liu T; Xiao Y; Wang X; Qian K
Cell Commun Signal; 2021 Mar; 19(1):34. PubMed ID: 33722247
[TBL] [Abstract] [Full Text] [Related]
13. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract] [Full Text] [Related]
14. cdkn1b mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
[TBL] [Abstract] [Full Text] [Related]
15. Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.
Metz EP; Wuebben EL; Wilder PJ; Cox JL; Datta K; Coulter D; Rizzino A
BMC Cancer; 2020 Oct; 20(1):941. PubMed ID: 32998722
[TBL] [Abstract] [Full Text] [Related]
16. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
[TBL] [Abstract] [Full Text] [Related]
17. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J
Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894
[TBL] [Abstract] [Full Text] [Related]
18. Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in prostate cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
Ebrahimizadeh W; Guérard KP; Rouzbeh S; Bramhecha YM; Scarlata E; Brimo F; Patel PG; Jamaspishvili T; Aprikian AG; Berman D; Bartlett JMS; Chevalier S; Lapointe J
J Mol Diagn; 2020 Oct; 22(10):1246-1263. PubMed ID: 32763409
[TBL] [Abstract] [Full Text] [Related]
19. miR-196a-mediated downregulation of p27
Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
[TBL] [Abstract] [Full Text] [Related]
20. Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human prostate (DU145) cancer Cells.
Singh SP; Mishra A; Shyanti RK; Singh RP; Acharya A
Biol Trace Elem Res; 2021 Apr; 199(4):1316-1331. PubMed ID: 32557113
[TBL] [Abstract] [Full Text] [Related]
[Next]
